Global In-Vitro Diagnostics Packaging Market Growth 2023-2029
In vitro diagnostic instruments are instruments that intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
LPI (LP Information)' newest research report, the “In-Vitro Diagnostics Packaging Industry Forecast” looks at past sales and reviews total world In-Vitro Diagnostics Packaging sales in 2022, providing a comprehensive analysis by region and market sector of projected In-Vitro Diagnostics Packaging sales for 2023 through 2029. With In-Vitro Diagnostics Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In-Vitro Diagnostics Packaging industry.
This Insight Report provides a comprehensive analysis of the global In-Vitro Diagnostics Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In-Vitro Diagnostics Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global In-Vitro Diagnostics Packaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In-Vitro Diagnostics Packaging and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In-Vitro Diagnostics Packaging.
The global In-Vitro Diagnostics Packaging market size is projected to grow from US$ 4844.8 million in 2022 to US$ 5878.3 million in 2029; it is expected to grow at a CAGR of 5878.3 from 2023 to 2029.
IVDs are highly sensitive to changes in their packaging environment. Moisture is typically the biggest degradation threat to IVDs. Oxygen and hydrocarbons are also a threat to IVD devices. When moisture, oxygen, and/or hydrocarbons are inside the packaging they could result in “inaccurate and inconsistent test results”.
This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Diagnostics Packaging market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Bottles
Vials
Tubes
Others
Segmentation by application
Hospitals
Laboratories
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Corning
Greiner
Narang Medical
Amcor
Gbf
Duran
Wheaton Industries
WS Packaging
Sarstedt
Key Questions Addressed in this Report
What is the 10-year outlook for the global In-Vitro Diagnostics Packaging market?
What factors are driving In-Vitro Diagnostics Packaging market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do In-Vitro Diagnostics Packaging market opportunities vary by end market size?
How does In-Vitro Diagnostics Packaging break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.